Archive: 12/03/2012

Clinical trial targets advanced prostate cancer

Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.

Dec 03, 2012
popularity 5 / 5 (1) | comments 0

Clinical trial hits new target in war on breast cancer

Breast cancers are defined by their drivers – estrogen and progesterone receptors (ER and PR) and HER2 are the most common, and there are drugs targeting each. When breast cancer has an unknown driver, it also has fewer ...

Dec 03, 2012
popularity 5 / 5 (5) | comments 0 | with audio podcast

FDA pledges support for med tech initiative

(AP)—The Food and Drug Administration says it will collaborate with medical device manufacturers on a public-private partnership designed to speed up the development of new medical technology.

Dec 03, 2012
popularity not rated yet | comments 0

'Junk DNA' drives embryonic development

An embryo is an amazing thing. From just one initial cell, an entire living, breathing body emerges, full of working cells and organs. It comes as no surprise that embryonic development is a very carefully ...

Dec 03, 2012
popularity 5 / 5 (9) | comments 21 | with audio podcast